Table 3.
The list of plasma metabolites obtained in +ESI, processed through Profinder and analyzed in MPP are arranged in ascending order of their mass range. Metabolites from the PLS-DA model without missing values were ranked according to the significance and variability and identified using various databases.
Sr. no. | Compounds | Mass (Da) | RT (min) | p Value (corrected) | FC (K vs P) | FC (K vs V) | FC (P vs V) | Abundance based order | ±PPM error |
---|---|---|---|---|---|---|---|---|---|
1 | LysoPC(22:5(7Z,10Z,13Z,16Z,19Z)) | 569.3544 | 29.83 | 9.37E−04 | 2.75 | 1.00 | −2.75 | K = V > P | −3.81 |
2 | Homoarginine | 188.1524 | 5.35 | 9.37E−04 | 2.81 | 1.01 | −2.77 | K = V > P | −9.69 |
3 | Unknown | 1016.679 | 36.00 | 9.37E−04 | 2.85 | 1.05 | −2.70 | K = V > P | – |
4 | Unknown | 278.1842 | 5.52 | 0.009072 | 2.31 | −1.00 | −2.32 | K = V > P | – |
5 | Unknown | 622.0015 | 5.39 | 4.28E−04 | 3.12 | 3.12 | −1 | K > P = V | – |
6 | 1-O-Sinapoyl-beta-d-glucose | 386.1439 | 5.77 | 0.01693 | 1.80 | 2.95 | 1.64 | K > P > V | −7.64 |
7 | Sphinganine | 301.2291 | 19.68 | 0.00583 | 1.93 | 3.29 | 1.70 | K > P > V | 0.57 |
8 | DG(18:3(9Z,12Z,15Z)/20:2(11Z,14Z)/0:0) | 642.4563 | 33.70 | 0.002483 | 2.57 | 2.97 | 1.15 | K > P > V | 4.43 |
9 | Hydroxyvalerylcarnitine | 263.2615 | 25.14 | 3.74E−04 | 3.02 | 3.45 | 1.14 | K > P > V | 2.48 |
10 | Unknown | 751.6487 | 5.25 | 0.008485 | 1.66 | 3.28 | 1.97 | K > P > V | – |
11 | N-Stearoylethanolamine | 327.3137 | 27.82 | 0.002483 | 2.76 | 1.28 | −2.16 | K > V > P | −5.71 |
12 | d-Threitol | 122.0383 | 9.02 | 0.002113 | 2.85 | 1.40 | −2.03 | K > V > P | −0.34 |
13 | 21-Hydroxydydrogesterone glucuronide | 504.2762 | 23.38 | 0.001943 | 2.90 | 1.47 | −1.96 | K > V > P | 3.82 |
14 | 8-Hydroxyguanine | 299.119 | 11.02 | 0.001819 | 2.96 | 2.05 | −1.44 | K > V > P | −11.99 |
15 | 2-Deoxyuridine | 228.1109 | 5.79 | 1.90E−04 | 3.30 | 1.21 | −2.74 | K > V > P | 5.02 |
16 | PS(19:0/0:0) | 539.3645 | 24.08 | 0.002217 | 2.82 | 1.35 | −2.08 | K > V > P | −4.78 |
17 | 2,3-Dinor-6-keto-prostaglandin F1α | 342.2884 | 23.04 | 0.002003 | 2.87 | 1.42 | −2.01 | K > V > P | 2.56 |
18 | PA(14:0/14:0) | 592.3261 | 22.66 | 0.001766 | 2.95 | 1.56 | −1.88 | K > V > P | −0.54 |
19 | Docosanamidoacetic acid | 397.356 | 29.87 | 0.002113 | 2.84 | 1.38 | −2.05 | K > V > P | −2.41 |
20 | 16-Hydroxypalmitic acid | 271.2516 | 24.22 | 6.06E−04 | 3.31 | 1.91 | −1.74 | K > V > P | −3.77 |
21 | Dibutyl phthalate | 278.1553 | 28.78 | 1.45E−06 | 3.72 | 1.31 | −2.87 | K > V > P | −3.15 |
22 | 2-Oxopentanoic acid | 116.0626 | 24.55 | 0.001766 | 2.98 | 2.08 | −1.43 | K > V > P | −4.77 |
23 | Argininosuccinic acid | 290.1134 | 23.41 | 0.001757 | 2.98 | 2.09 | −1.42 | K > V > P | −3.34 |
24 | l-Kynurenine | 208.1097 | 23.40 | 4.40E−04 | 3.33 | 1.67 | −1.99 | K > V > P | −7.95 |
25 | 1α,25-dihydroxy-11-(4-hydroxymethylphenyl)-9,11-didehydrovitamin D3 | 520.4126 | 33.94 | 0.002678 | 2.79 | 1.37 | −2.02 | K > V > P | −4.17 |
26 | Unknown | 287.2827 | 23.78 | 0.001819 | 2.96 | 2.04 | −1.45 | K > V > P | – |
27 | 3-Hydroxyoctanoyl carnitine | 303.2051 | 15.69 | 0.001701 | 2.99 | 2.11 | −1.41 | K > V > P | 6.92 |
28 | 4-Methylthio-2-oxobutanoic acid | 148.0159 | 35.41 | 0.017991 | 2.40 | 1.47 | −1.63 | K > V > P | 0.56 |
29 | Paired-like homeodomain transcription factor 3 | 8804.468 | 20.27 | 0.001903 | 2.95 | 2.03 | −1.45 | K > V > P | 6.89 |
30 | l-Octanoylcarnitine | 287.2493 | 25.20 | 1.90E−04 | 3.30 | 1.20 | −2.74 | K > V > P | −7.77 |
31 | Unknown | 735.6437 | 35.91 | 0.001766 | 2.97 | 2.06 | −1.43 | K > V > P | – |
32 | 2-Methoxyestrone | 300.1383 | 9.037 | 9.37E−04 | −2.76 | 1 | 2.76 | P > K = V | −4.52 |
33 | N-Docosanoyl taurine | 447.3026 | 20.11 | 9.37E−04 | −2.76 | 1 | 2.76 | P > K = V | 4.68 |
34 | L-2,4-diaminobutanoate | 118.0425 | 8.82 | 1.90E−04 | −3.07 | 1 | 3.07 | P > K = V | −5.95 |
35 | Capryloylglycine | 201.1733 | 8.75 | 9.37E−04 | −2.76 | −1.00 | 2.76 | P > K = V | −4.84 |
36 | Malonuric acid | 146.0374 | 8.83 | 1.90E−04 | −3.07 | −1 | 3.07 | P > K = V | 5.92 |
Transcription factor HFK1 | 15,119.04 | 17.82 | 9.37E−04 | −2.75 | −1 | 2.75 | P > K = V | 8.55 | |
38 | Unknown | 303.2065 | 15.20 | 9.37E−04 | −2.75 | −1 | 2.75 | P > K = V | – |
39 | Coumaric acid | 164.0482 | 8.83 | 9.37E−04 | −2.69 | 1.14 | 3.07 | P > K > V | −8.61 |
40 | 5-Methylcytosine | 125.0846 | 10.92 | 0.004456 | −2.33 | 1.16 | 2.71 | P > K > V | −8.74 |
41 | LysoPC(18:0) | 523.3677 | 26.96 | 0.017991 | −1.85 | 1.41 | 2.62 | P > K > V | −5.17 |
42 | Benzoic acid | 122.0374 | 8.83 | 9.37E−04 | −2.65 | 1.15 | 3.06 | P > K > V | −9.66 |
43 | Traumatic acid | 228.1488 | 8.79 | 9.37E−04 | −2.76 | −1.00 | 2.76 | P > V = K | 4.26 |
44 | 1,25-Dihydroxyvitamin D3 3-glycoside | 578.2892 | 24.66 | 9.37E−04 | −2.76 | −1 | 2.76 | P > V = K | 0.15 |
45 | (2E,6E,8E)N-Isobutyl-2,6,8-hexadecatriene-10-yneamide | 301.2272 | 19.45 | 9.37E−04 | −2.76 | −1 | 2.76 | P > V = K | 2.42 |
46 | Putative reverse transcriptase | 6626.596 | 17.88 | 9.37E−04 | −2.75 | −1 | 2.75 | P > V = K | 7.45 |
47 | Inositol cyclic phosphate | 242.0381 | 11.36 | 0.004514 | −2.70 | −1.39 | 1.94 | P > V > K | 0.09 |
48 | 12α-Hydroxyerosone | 368.1073 | 10.06 | 0.004862 | −2.67 | −1.42 | 1.87 | P > V > K | −2.51 |
49 | Guanidinoacetic acid | 117.0583 | 12.14 | 0.004862 | −2.66 | −1.43 | 1.86 | P > V > K | −8.61 |
50 | Glycochenodeoxycholate | 449.3177 | 23.00 | 0.005034 | −2.66 | −1.49 | 1.84 | P > V > K | 8.88 |
51 | Melatonin | 232.1593 | 13.85 | 0.005267 | −2.65 | −1.45 | 1.82 | P > V > K | −1.97 |
52 | 10-Formyl tetrahydrofolyl l-glutamate | 602.2897 | 24.73 | 9.37E−04 | −2.76 | −1 | 2.76 | P > V > K | 0.14 |
53 | 21-Hydroxypregnenolone | 332.1452 | 31.32 | 0.006784 | −2.61 | −2.01 | 1.29 | P > V > K | −8.83 |
54 | LysoPE(18:3(6Z,9Z,12Z)/0:0) | 475.2726 | 25.23 | 0.005976 | −2.64 | −1.93 | 1.36 | P > V > K | −3.17 |
55 | N-Heptanoylglycine | 187.0642 | 12.11 | 0.004414 | −2.71 | −1.37 | 1.97 | P > V > K | 9.5 |
56 | 2-Hydroxy-13-O-d-glucuronoside-octadec-9Z-enoate | 490.3318 | 13.84 | 0.004862 | −2.67 | −1.43 | 1.87 | P > V > K | −8.2 |
57 | Dehydrospermidine | 143.0739 | 12.14 | 0.004862 | −2.67 | −1.42 | 1.88 | P > V > K | −14.42 |
58 | 9-Hydroxyphenanthrene | 194.0813 | 12.50 | 0.005181 | −2.65 | −1.43 | 1.85 | P > V > K | 7.51 |
59 | Valine | 117.0582 | 11.36 | 0.004414 | −2.71 | −1.37 | 1.96 | P > V > K | −7.75 |
60 | 6-Amino-2-oxohexanoate | 145.0533 | 12.14 | 0.004862 | −2.66 | −1.43 | 1.86 | P > V > K | −4.15 |
61 | Valerenic acid | 234.1746 | 13.85 | 0.004862 | −2.67 | −1.42 | 1.87 | P > V > K | −8.3 |
62 | 2-(3-Carboxy-3-aminopropyl)-l-histidine | 256.1567 | 13.84 | 0.004862 | −2.67 | −1.42 | 1.87 | P > V > K | −7.36 |
63 | 1α-hydroxy-2β-(5-hydroxypentoxy) vitamin D3 | 502.3023 | 13.62 | 0.004862 | −2.68 | −1.41 | 1.90 | P > V > K | 1.98 |
64 | Unknown | 287.2481 | 22.81 | 0.004514 | −2.70 | −1.38 | 1.94 | P > V > K | – |
65 | l-Hexanoylcarnitine | 259.18 | 15.11 | 0.004862 | −2.67 | −1.42 | 1.88 | P > V > K | 3.78 |
66 | beta-Alanyl-l-arginine | 245.164 | 12.58 | 9.37E−04 | −3.02 | −1.39 | 2.16 | P > V > K | −6.56 |
67 | Splicing factor 1 isoform 4 | 15,859.4 | 17.68 | 9.37E−04 | −2.76 | −1 | 2.76 | P > V > K | 6.88 |
68 | Catechin | 290.1154 | 23.17 | 0.004862 | −2.66 | −1.43 | 1.86 | P > V > K | 3.65 |
69 | 16,17-Epoxydeoxycorticosterone acetate | 386.1762 | 22.61 | 0.004862 | −2.67 | −1.43 | 1.86 | P > V > K | 5.92 |
70 | Unknown | 1895.032 | 11.48 | 0.004537 | −2.69 | −1.39 | 1.93 | P > V > K | – |
71 | l-Aspartate 4-semialdehyde | 117.0789 | 5.52 | 0.001141 | 2.72 | −1.00 | −2.73 | V > K > P | −4.05 |
72 | 1α,25-dihydroxy-26,27-dipropylvitamin D3 | 500.4923 | 28.41 | 9.37E−04 | 2.76 | −1.03 | −2.86 | V > K > P | 6.72 |
73 | Unknown | 471.8662 | 5.00 | 0.005393 | 1.10 | −2.83 | −3.13 | V > K > P | – |
74 | Unknown | 444.2072 | 23.98 | 0.0033 | −2.56 | −2.84 | −1.11 | V > P > K | – |
75 | 10,11-Dihydro-20-trihydroxy-leukotriene B4 | 386.2481 | 22.15 | 9.37E−04 | −2.76 | −1 | 2.76 | V > P > K | −10.48 |
76 | DG(14:0/14:1(9Z)/0:0) | 510.392 | 36.17 | 0.013222 | −2.02 | −2.86 | −1.41 | V > P > K | 0.71 |
Abbreviations: RT – retention time, p – calculated probability and FC – fold change.